New Drug Combination Helps Stem Cell Therapy for Leukemia
NYU Langone study shows that a new drug combination prevents graft-versus-host disease in patients receiving stem cell transplants for leukemia.
New Drug Effective for Aggressive Form of Lung Cancer
NYU Langone medical oncologist Dr. Vamsidhar Velcheti discusses a new treatment for an aggressive form of non-small cell lung cancer.
New Drug Effective in Lung Cancers Caused by Genetic Error
NYU Langone research finds a new drug that can reduce the size of lung cancer tumors in people with a specific, disease-causing genetic change.
New Drug May Treat More People With Metastatic Breast Cancer
Dr. Sylvia Adams, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, discusses a new treatment for metastatic breast cancer.
New Drug More Effective in Treating Rare Kidney Disease
New study finds that sparsentan is an effective treatment for the rare kidney disease focal segmental glomerulosclerosis (FSGS).
New Drug Offers Relief for Treatment-Resistant Epilepsy
NYU Langone study shows that new drug XEN1101 reduces seizure frequency and sometimes prevents them altogether in people with focal epilepsy.
New Drug Shows Promise in Treating an Aggressive Skin Cancer
The drug pembrolizumab (Keytruda) has proved successful in preventing a rare, aggressive form of skin cancer, according to study led by NYU Langone researchers.
New Drug Slows Progression of Advanced Breast Cancer
NYU Langone breast cancer expert Dr. Sylvia Adams discusses a new drug that slows the progression of advanced breast cancer.
New Eye Tracker Detects Concussion
Research conducted on patients with head trauma who visited emergency department shows eye tracking may detect concussion severity.
new-faculty-appointments.pdf
School of Medicine Announcement of Appointments, July 2025 – August 2025 Sajan Acharya Clinical Assistant ...